Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$36.81 - $48.12 $1.31 Million - $1.71 Million
35,606 Added 694.21%
40,735 $1.68 Million
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $183,002 - $229,317
5,129 New
5,129 $211,000
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $200,892 - $239,369
-3,530 Closed
0 $0
Q2 2021

Aug 26, 2021

BUY
$64.02 - $71.72 $225,990 - $253,171
3,530 New
3,530 $239,000
Q2 2021

Aug 12, 2021

BUY
$64.02 - $71.72 $0 - $0
0 New
0 $239,000
Q1 2021

May 12, 2021

SELL
$53.26 - $68.08 $550,974 - $704,287
-10,345 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$43.41 - $56.51 $449,076 - $584,595
10,345 New
10,345 $585,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.